152 related articles for article (PubMed ID: 2874330)
1. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.
Rosove MH; Perloff JK; Hocking WG; Child JS; Canobbio MM; Skorton DJ
Lancet; 1986 Aug; 2(8502):313-5. PubMed ID: 2874330
[TBL] [Abstract][Full Text] [Related]
2. Adults with cyanotic congenital heart disease: hematologic management.
Perloff JK; Rosove MH; Child JS; Wright GB
Ann Intern Med; 1988 Sep; 109(5):406-13. PubMed ID: 3044212
[TBL] [Abstract][Full Text] [Related]
3. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
DeFilippis AP; Law K; Curtin S; Eckman JR
Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881
[TBL] [Abstract][Full Text] [Related]
4. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
Braun SL; Eicken A; Kaemmerer H
Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
[TBL] [Abstract][Full Text] [Related]
5. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.
Blanche C; Alonso-Gonzalez R; Uribarri A; Kempny A; Swan L; Price L; Wort SJ; Beghetti M; Dimopoulos K
Int J Cardiol; 2018 Sep; 267():79-83. PubMed ID: 29807779
[TBL] [Abstract][Full Text] [Related]
6. Risk of stroke in adults with cyanotic congenital heart disease.
Perloff JK; Marelli AJ; Miner PD
Circulation; 1993 Jun; 87(6):1954-9. PubMed ID: 8504509
[TBL] [Abstract][Full Text] [Related]
7. Clinical update: cyanotic adult congenital heart disease.
Spence MS; Balaratnam MS; Gatzoulis MA
Lancet; 2007 Nov; 370(9598):1530-2. PubMed ID: 17980725
[No Abstract] [Full Text] [Related]
8. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.
Broberg CS; Bax BE; Okonko DO; Rampling MW; Bayne S; Harries C; Davidson SJ; Uebing A; Khan AA; Thein S; Gibbs JS; Burman J; Gatzoulis MA
J Am Coll Cardiol; 2006 Jul; 48(2):356-65. PubMed ID: 16843187
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease.
Rosenthal A; Nathan DG; Marty AT; Button LN; Miettinen OS; Nadas AS
Circulation; 1970 Aug; 42(2):297-308. PubMed ID: 5431926
[No Abstract] [Full Text] [Related]
10. Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease.
Cordina RL; Celermajer DS
Cardiol Young; 2010 Jun; 20(3):242-53. PubMed ID: 20416139
[TBL] [Abstract][Full Text] [Related]
11. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis.
Rose SS; Shah AA; Hoover DR; Saidi P
J Gen Intern Med; 2007 Dec; 22(12):1775-7. PubMed ID: 17917783
[TBL] [Abstract][Full Text] [Related]
12. Serum Iron Status of Children with Cyanotic Congenital Heart Disease in Lagos, Nigeria.
Itiola AY; Animasahun BA; Njokanma OF
Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e345-e351. PubMed ID: 31897318
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease.
Oldershaw PJ; Sutton MG
Br Heart J; 1980 Nov; 44(5):584-8. PubMed ID: 7437201
[TBL] [Abstract][Full Text] [Related]
14. A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease.
Gaiha M; Sethi HP; Sudha R; Arora R; Acharya NR
Indian Heart J; 1993; 45(1):53-5. PubMed ID: 8365742
[TBL] [Abstract][Full Text] [Related]
15. [Normal hemoglobin levels in children with cyanotic heart disease. Is it iron deficiency anemia?].
Hågå P
Tidsskr Nor Laegeforen; 1993 May; 113(14):1710-1. PubMed ID: 8322297
[TBL] [Abstract][Full Text] [Related]
16. Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations.
Santhirapala V; Williams LC; Tighe HC; Jackson JE; Shovlin CL
PLoS One; 2014; 9(3):e90777. PubMed ID: 24637882
[TBL] [Abstract][Full Text] [Related]
17. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
Zabala LM; Guzzetta NA
Paediatr Anaesth; 2015 Oct; 25(10):981-9. PubMed ID: 26184479
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease.
Reiss UM; Bensimhon P; Zimmerman SA; Ware RE
Am J Hematol; 2007 Aug; 82(8):740-3. PubMed ID: 17506064
[TBL] [Abstract][Full Text] [Related]
19. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
[TBL] [Abstract][Full Text] [Related]
20. Parameters of iron deficiency in children with cyanotic congenital heart disease.
Olcay L; Ozer S; Gürgey A; Saraçlar M; Ozme S; Bilgiç A; Ozkutlu S; Celiker A
Pediatr Cardiol; 1996; 17(3):150-4. PubMed ID: 8662027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
